STAT3 and neoplasm: Several studies indicated that STAT3, an important transcription factor in tumors, was downstream of the Wnt pathway [16, 22, 23] and our previous research found that STAT3 inhibitor WP1066 exhibited anti-tumor effects in lymphoma [24].